NewBridge Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2010
Total raised
- $12M
Investors
- 2
About NewBridge Pharmaceuticals
NewBridge Pharmaceuticals is a pharmaceutical company specializing in the commercialization of innovative therapies through in-licensing agreements.NewBridge Pharmaceuticals operates as a specialized commercialization platform, actively engaging in the in-licensing of innovative healthcare solutions from global pharmaceutical firms. The company is headquartered in Dubai, United Arab Emirates.NewBridge Pharmaceuticals operates as a First-in-Class commercialization platform, focusing on the in-licensing of innovative therapies from global pharmaceutical firms. The company primarily serves the MENA region, striving to bridge the access gap for patients in these countries. Their core product offerings are centered around advanced therapeutic solutions designed to address critical healthcare needs across various therapy areas.NewBridge Pharmaceuticals generates revenue through partnerships and collaborations with global pharmaceutical companies, focusing on the commercialization and distribution of licensed products in the MENA region. Their revenue model is structured around agreements that enable the company to bring innovative therapies to market, creating pathways for B2B partnerships with healthcare providers and potential direct interactions with consumers via healthcare channels. The company is currently developing additional therapeutic solutions, with plans to launch new products aimed at addressing unmet medical needs.
Who invested in NewBridge Pharmaceuticals
2 investors across 1 round
See all investors in NewBridge Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 20, 2010
Amount
$12M
Investors
Questions about NewBridge Pharmaceuticals
Who invested in NewBridge Pharmaceuticals?
NewBridge Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NewBridge Pharmaceuticals raised?
NewBridge Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NewBridge Pharmaceuticals last raise money?
NewBridge Pharmaceuticals's most recent round on record is a Series B, in Sep 2010.
What does NewBridge Pharmaceuticals do?
NewBridge Pharmaceuticals is a pharmaceutical company specializing in the commercialization of innovative therapies through in-licensing agreements.
Where is NewBridge Pharmaceuticals headquartered?
NewBridge Pharmaceuticals is headquartered in Dubai, United Arab Emirates.
Which VCs invest in companies like NewBridge Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at NewBridge Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like NewBridge Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.